<- Go Home
Drugs Made In America Acquisition II Corp.
Drugs Made In America Acquisition II Corp. does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combination with one or more businesses. It intends to source and evaluate companies focused on the pharmaceutical sector. Drugs Made In America Acquisition II Corp. was incorporated in 2024 and is based in New York, New York.
Market Cap
$638.9M
Volume
181.3K
Cash and Equivalents
$223.00
EBITDA
N/A
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
N/A
Profit Margin
N/A
52 Week High
$10.03
52 Week Low
$9.86
Dividend
N/A
Price / Book Value
-35.94
Price / Earnings
66.39
Price / Tangible Book Value
-35.94
Enterprise Value
$638.9M
Enterprise Value / EBITDA
N/A
Operating Income
-$1.3M
Return on Equity
46.80%
Return on Assets
-0.32
Cash and Short Term Investments
$223.00
Debt
N/A
Equity
-$17.8M
Revenue
N/A
Unlevered FCF
-$499.9K
Sector
Capital Markets
Category
N/A